Devyser Diagnostics AB
DVYSR SE0016588867
ICB 2010 : Health Care / Health CareAnnual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-0% | -17% | 10% | 53% | -2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Jan Wahlström CEO |
151.80 SEK |
3,351 Bought |
508,682 SEK |
03/09/2025 | 01/09/2025 |
Mia Arnhult CB |
99.38 SEK |
6,608 Bought |
656,703 SEK |
30/05/2025 | 28/05/2025 |
Fredrik Dahl CEO |
105.80 SEK |
10,000 Bought |
1,058,000 SEK |
08/05/2025 | 07/05/2025 |
Mia Arnhult CB |
106.47 SEK |
7,000 Bought |
745,290 SEK |
17/03/2025 | 14/03/2025 |
Mia Arnhult CB |
114.71 SEK |
500 Bought |
57,355 SEK |
11/03/2025 | 10/03/2025 |
Mia Arnhult CB |
115.92 SEK |
1,000 Bought |
115,920 SEK |
11/03/2025 | 07/03/2025 |
Lars Höckenström DIR |
130.50 SEK |
10,000 Sold |
1,305,000 SEK |
21/02/2025 | 20/02/2025 |
Fredrik Alpsten CEO |
127.97 SEK |
4,000 Bought |
511,890 SEK |
30/10/2024 | 30/10/2024 |
Fredrik Alpsten CEO |
108.00 SEK |
3,000 Bought |
324,000 SEK |
23/07/2024 | 23/07/2024 |
Mia Arnhult CB |
107.00 SEK |
100,000 Bought |
10,700,000 SEK |
25/06/2024 | 20/06/2024 |